Company Information

  

Address: 530 FAIRVIEW AVENUE NORTH  
City: SEATTLE 
State: WA 
Zip Code: 98109 
Telephone: 206-378-6266 

Description of Business

Primary SIC Code: 2836
(As filed with the SEC)  

We develop, manufacture and sell robust, intuitive products that unlock scientifically valuable and clinically actionable biologic information from minute amounts of tissue. Our nCounter Analysis System directly profiles hundreds of molecules simultaneously using a novel barcoding technology that is powerful enough for use in research, yet simple enough for use in clinical laboratories worldwide. We market systems and related consumables to researchers in academic, government, and biopharmaceutical laboratories for use in understanding fundamental biology and the molecular basis of disease and to clinical laboratories and medical centers for diagnostic use. As of December 31, 2016, we have an installed base of approximately 480 systems, which our customers have used to publish over 1,450 peer-reviewed papers.  ... More ...  

Per Share Overview

Date 12-mos Rolling EPS Dividend P/E Ratio
09/2017-2.05NAN/E
06/2017-2.11NAN/E
03/2017-2.47NAN/E
12/2016-2.34NAN/E
09/2016-2.24NAN/E
06/2016-2.22NAN/E
03/2016-2.33NAN/E
12/2015-2.40NAN/E

Key Financial Ratios and Statistics

FYE: 12/31

Profitability 2016 Leverage 2016
Net Inc/Comm Equity-0.17Total Liab/Total Assets0.90
Net Inc/Total Assets-0.37Total Liab/Inv Cap1.27
Net Inc/Inv Cap-0.52Total Liab/Comm Equity0.40
Pretax Inc/Net Sales-0.54Interest Coverage Ratio-7.28
Net Inc/Net Sales-0.54Curr Debt/Equity0.00
Cash Flow/Net Sales-0.07LTD/Equity3.85
SG&A/NetSales0.72Total Debt/Equity3.85
Asset Utilization   Liquidity  
Net Receivables Turnover4.13Quick Ratio2.75
Inventory Turnover2.53Current Ratio3.13
Inventory Day Sales0.01Net Rec/Curr Assets0.20
Net Sales/Work Cap1.12Inv/Curr Assets0.12
Net Sales/PP&E7.11  

Income Statement (Millions)

  9/30/2017 6/30/2017 3/31/2017 12/31/2016
Total Revenues(Net Sales) 27.02 34.59 18.06 25.23
Cost of Goods Sold 7.31 8.22 7.16 8.43
Selling & Admin Exps 18.38 18.65 17.57 16.68
Operating Income -10.04 -3.31 -17.47 -9.88
Interest Exp 1.56 1.53 1.50 1.52
Pretax Income -11.36 -4.51 -18.81 -11.55
Other Income 0.24 0.33 0.16 -0.15
Net Income Bef Extraordinary ... NA NA NA NA
Net Income -11.40 -4.56 -18.85 -11.59

Balance Sheet (Millions)

Assets 9/30/2017 6/30/2017 3/31/2017 12/31/2016
Cash & Short Term Investments 89.85 99.34 57.14 74.04
Receivables - Total 18.29 18.48 16.73 22.19
Inventories - Total 18.52 15.76 14.54 13.81
Total Current Assets 132.77 138.88 92.37 113.79
Net Property, Plant & Equipment 13.87 13.64 13.66 12.16
Total Assets 147.19 153.04 106.53 126.37
Liabilities        
Accounts Payable 22.44 15.38 11.26 17.28
Debt in Current Liabilities 0.00 0.00 0.03 0.06
Total Current Liabilities 39.59 32.89 32.42 36.38
Long-Term Debt 48.53 48.14 47.75 47.37
Total Liabilities 102.12 101.02 109.59 114.07
Stockholder's Equity        
Minority Interest NA NA NA NA
Preferred Stock 0.00 0.00 0.00 0.00
Common Stock 0.00 0.00 0.00 0.00
Retained Earnings -304.35 -292.95 -288.39 -269.54
Treasury Stock NA NA NA NA
Total Stockholders' Equity 45.07 52.02 -3.06 12.31
Total Liabilities and Stockholders' Equity 147.19 153.04 106.53 126.37

Cash Flow Summary (Millions)

Categories 9/30/2017 6/30/2017 3/31/2017 12/31/2016
Net Cash Provided by Operating Activities -10.34 -13.70 -15.27 -6.43
Net Cash Provided by Investing Activities -2.79 -7.85 -0.84 -11.56
Net Cash Provided by Financing Activities 1.27 56.77 0.93 28.13

Annual Summary Data (Millions)

Year Sales Net Income EPS
12/201222.97-17.71--
12/201331.40-29.28-4.44
12/201447.59-50.04-2.80
12/201562.67-45.58-2.40
12/201686.49-47.09-2.34
Growth Rates39.30----

Stock Ownership

Type Date(Q,M) No. Owners Shares Held (000s) % Own
Institutional09/30/1710523,42292.28




Report Date : 12/11/2017

Powered By Edgar Online © 2017EDGAR®Online, a division of Donnelley Financial Solutions. EDGAR® is a federally registered trademark of the U.S. Securities and Exchange Commission. EDGAR Online is not affiliated with or approved by the U.S. Securities and Exchange Commission.